Sort
51,570 grants matching “autoimmune disease”
The KQ1 serum study: soluble biomarkers for T1D risk, development & progression
$1,095,529Dirk Homann · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
The Role of B cells in the Origin and Progression of Multiple Sclerosis
$1,095,360Stephen L Hauser · University Of California, San Francisco · R35 · FY2024 · NS
Novel Interactions Between the Immune and Neuroendocrine Systems
$1,094,753Dennis D. Taub · National Institute On Aging · ZIA · FY2010 · AG
Epigenetic Regulation of T cell differentiation
$1,094,736Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$1,094,640Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Atoms-to-Animals: Structural Genomics of Immunity
$1,094,237Stanley G Nathenson · Albert Einstein College Of Medicine · U01 · FY2011 · GM
Atoms-to-Animals: Structural Genomics of Immunity
$1,094,237Arturo Casadevall · Albert Einstein College Of Medicine · U01 · FY2012 · GM
CEACAM5-targeted activation of potent chemotherapeutics via bioorthogonal click chemistry
$1,094,189Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2025 · CA
Gene Regulation In The Immune System
$1,094,006Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
Advanced Pre-Clinical Development of O2LineTM System for Type 1 Diabetes Cell Therapy
$1,093,967Linda Ann Tempelman · Persista Bio Inc · R44 · FY2025 · DK
Research Resources: Epigenomic and Transcriptomic Profile of Human Immune Cells
$1,093,781Pandurangan Vijayanand · La Jolla Institute For Immunology · R24 · FY2023 · AI
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$1,092,899Dorothy Anne Cross · Washington University · P01 · FY2009 · NS
B-CELL TARGETED INDUCTION TO IMPROVE OUTCOMES IN PEDIATRIC LUNG TRANSPLANTATION
$1,092,701Stuart C Sweet · Washington University · U01 · FY2016 · AI
Novel PARS inhibitor for therapy of colitis
$1,092,059Inotek Pharmaceuticals Corporation · R44 · FY2001 · DK
Immunological identity redefined by genetically foreign microchimeric cells
$1,092,000Sing Sing Way · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2016 · AI
Immunological identity redefined by genetically foreign microchimeric cells
$1,092,000Sing Sing Way · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2017 · AI
Immunological identity redefined by genetically foreign microchimeric cells
$1,092,000Sing Sing Way · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2020 · AI
Immunological identity redefined by genetically foreign microchimeric cells
$1,092,000Sing Sing Way · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2019 · AI
Pioneering assays for spatially-resolved single-cell multiomics
$1,091,941Lin Pham · Survey Genomics, Inc. · R44 · FY2025 · HG
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$1,090,900Florence Burleson · · N01 · FY2023 · ES
Boston Area Diabetes and Endocrinology Research Center (BADERC)
$1,090,690Alexander A Soukas · Massachusetts General Hospital · P30 · FY2023 · DK
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,090,680Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Research Resources: Epigenomic and Transcriptomic Profile of Human Immune Cells
$1,090,250Pandurangan Vijayanand · La Jolla Institute For Immunology · R24 · FY2022 · AI
A Haplotype Map for Multiple Sclerosis
$1,089,455Stephen L Hauser · University Of California, San Francisco · R01 · FY2010 · NS
Stanford Precision Health for Ethnic and Racial Equity (SPHERE) Transdisciplinary Collaborative Center
$1,089,399Yvonne A. Maldonado · Stanford University · U54 · FY2021 · MD